InvestorsHub Logo
icon url

Ultraz2

12/16/17 12:36 PM

#149665 RE: flipper44 #149664

I agree...this is excellent...why keep cancer patients on steroids that increase glucose and feed the tumor and decrease the immune response is beyond me...I understand it’s to decrease swelling, but it is so back %#$.
icon url

Al4door

12/16/17 12:51 PM

#149667 RE: flipper44 #149664

Maybe there is some way to extrapolate the time sequence or at minimum a little discussion as to the time lag that occur with these therapys. Obviously the fact that Avastin received the approval is that they submitted data to the FDA. If we consider that the data was submitted X months ago, maybe you can estimate that, inorder to get an approval a certain amount of time had to have transpired. What other threapys are in the pipeline and now that the first one was approved would the next be shorter or longer and how much time does one believe it will take. I don't know anything about Avastin's therapy or when it was trialed and when it was submitted but it had to be in the pipeline under the old FDA and then reviewed by the new FDA or was it just submitted to the new and improved FDA and approved, again I don't know. But clearly a new path to approval for immunotherapy is apparent now.

We therefore must be on the cusp of something enormous and game changing since our therapy kicks Avastin's ass in all respects. One would think that alone would make the new FDA take a little more time with our approval but to grant our approval nonetheless.